TY - JOUR AU - Emens, L A; Esteva, F; Beresford, M TI - Results from KATE2, a randomized phase 2 study of atezolizumab (atezo) + trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC) JO - Cancer Res IS - S04 VL - 79 PY - 2019 DO - 10.1158/1538-7445.SABCS18-PD3-01 L3 - PubMed-ID: 30610085 SP - PD3-01 ER -